text
"['\nX. 대주주 등과의 거래내용\n(1) 당분기 및 전분기 중 회사와 매출 등 거래 또는 채권, 채무 잔액이 있는 특수관계자 현황은 다음과 같습니다.\n관 계\n회 \xa0 \xa0 사 \xa0 \xa0 명\n종속기업\n(주)유한화학, (주)유한메디카, (주)엠지, (주)유한건강생활, 애드파마(주), YUHANUZBEKISTAN, 암호명케이문화산업전문(유), YUHAN USA CORPORATION, (주)에이투젠\n관계기업 및 공동기업\n유한킴벌리(주), (주)유칼릭스, (주)유한크로락스, (주)한국얀센, (주)이뮨온시아, (주)씨.앤.씨, (주)워랜텍, (주)휴이노, (주)메디오젠, 메디라마(주), 에스비바이오팜(주), (주)제이인츠바이오, (주)온코마스터, (주)테라베스트,(주)아임뉴런바이오사이언스, 주노랩(주), (주)엔솔바이오사이언스, (주)지아이이노베이션, (주)에이프릴바이오, (주)네오딘바이오벳\n기타특수관계자\n(주)리드팜, 류신(칭다오)건강(유), (주)내츄럴엔도텍, (주)유앤생명과학\n(2) 당분기 및 전분기 중 특수관계자와의 거래 내역은 다음과 같습니다.\n- 당분기\n\xa0(단위:천원)\n특수관계자의 명칭\n제상품매출\n임대, 용역수익\n기타(잡이익등)\n배당금수익\n매입등\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n(종속기업)\n\xa0(주)유한화학\xa0\n-\n3,600\n-\n-\n-\n-\n-\n-\n29,757,127\n122,884,015\n\xa0(주)유한메디카\n-\n159\n6,900\n20,700\n-\n-\n-\n-\n760,597\n760,597\n\xa0(주)엠지\n-\n-\n8,970\n26,910\n-\n-\n-\n-\n4,533,440\n11,834,208\n\xa0(주)유한건강생활\n28,187\n28,187\n199,900\n672,607\n-\n30,000\n-\n-\n2,810,564\n11,742,554\n\xa0애드파마(주)\n-\n-\n1,560\n4,680\n-\n-\n-\n-\n2,480,800\n9,787,118\n소 계\n28,187\n31,946\n217,330\n724,897\n-\n30,000\n-\n-\n40,342,528\n157,008,492\n(관계기업 및 공동기업)\n\xa0유한킴벌리(주)\n-\n-\n-\n-\n-\n-\n-\n97,800,000\n54,000\n255,213\n\xa0(주)유한크로락스\n-\n1,657\n401,241\n1,120,955\n-\n-\n-\n2,198,000\n20,322,840\n56,106,325\n\xa0(주)한국얀센\n-\n-\n78,574\n385,718\n-\n-\n-\n5,536,450\n9,680,102\n29,473,588\xa0\n\xa0(주)유칼릭스\n-\n-\n-\n-\n-\n-\n-\n40,800\n18,156\n53,921\n\xa0(주)엔솔바이오사이언스\n-\n-\n-\n-\n-\n-\n-\n-\n587,010\n587,010\n\xa0(주)이뮨온시아\n-\n-\n936\n22,808\n-\n1,200\n-\n-\n-\n-\n\xa0(주)씨.앤.씨\xa0\n-\n-\n-\n-\n-\n-\n-\n-\n1,918,088\n5,522,661\n\xa0(주)워랜텍\n-\n-\n-\n-\n-\n-\n-\n-\n2,095,592\n5,823,954\n\xa0(주)지아이이노베이션\n-\n-\n-\n-\n-\n-\n-\n-\n3,500,000\n3,500,000\n\xa0(주)휴이노\n-\n-\n-\n-\n-\n-\n-\n-\n975,000\n1,241,150\n\xa0(주)메디오젠\n-\n-\n-\n-\n-\n-\n-\n234,570\n185,900\n2,836,131\n\xa0(주)에이프릴바이오\n-\n-\n-\n-\n-\n-\n-\n-\n200,000\n200,000\n\xa0에스비바이오팜(주)\n-\n-\n-\n-\n-\n-\n-\n-\n(3,518,591)\n(238,004)\n\xa0메디라마(주)\n-\n-\n21,987\n51,303\n-\n-\n-\n-\n60,000\n120,000\n\xa0(주)온코마스터\n-\n-\n1\n1\n-\n-\n-\n-\n-\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0소 계\n-\n1,657\n502,739\n1,580,785\n-\n1,200\n-\n105,809,820\n36,078,097\n105,481,949\n(기타특수관계자)\n\xa0(주)리드팜\n676,283\n2,077,825\n-\n-\n-\n-\n-\n-\n995\n2,918\n\xa0류신(칭다오)건강(유)\n-\n-\n-\n-\n-\n-\n-\n-\n245\n1,872\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0소 계\n676,283\n2,077,825\n-\n-\n-\n-\n-\n-\n1,240\n4,790\n합 계\xa0\n704,470\n2,111,428\n720,069\n2,305,682\n-\n31,200\n-\n105,809,820\n76,421,865\n262,495,231\n- 전분기\n\xa0(단위:천원)\n특수관계자의 명칭\n제상품매출\n임대, 용역수익\n기타(잡이익등)\n배당금수익\n매입등\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n3개월\n누적\n(종속기업)\n\xa0(주)유한화학\xa0\n1,910\n3,710\n-\n-\n-\n-\n-\n-\n43,197,142\n112,532,360\n\xa0(주)유한메디카\n1,455\n2,909\n6,900\n20,700\n-\n29,878\n-\n-\n35,555,272\n35,555,272\n\xa0(주)엠지\n-\n-\n8,970\n26,910\n-\n-\n-\n-\n3,929,539\n9,265,690\n\xa0(주)유한건강생활\n-\n-\n268,368\n869,672\n105,554\n117,284\n-\n-\n2,693,818\n8,128,326\n\xa0애드파마(주)\n-\n-\n1,560\n33,076\n-\n5,000\n-\n-\n2,173,818\n8,216,477\n소 계\n3,365\n6,619\n285,798\n950,358\n105,554\n152,162\n-\n-\n87,549,589\n173,698,125\n(관계기업 및 공동기업)\n\xa0(주)유칼릭스\n-\n-\n-\n-\n-\n-\n-\n40,800\n15,302\n46,426\n\xa0(주)유한크로락스\n-\n-\n445,231\n1,233,996\n-\n-\n-\n2,747,500\n21,469,328\n54,891,008\n\xa0유한킴벌리(주)\n-\n-\n-\n-\n-\n-\n-\n19,500,000\n71,238\n777,018\n\xa0(주)한국얀센\n-\n-\n204,661\n386,623\n-\n-\n-\n-\n9,155,232\n27,954,479\n\xa0(주)이뮨온시아\n-\n-\n936\n2,808\n900\n2,700\n-\n-\n-\n-\n\xa0(주)씨.앤.씨\xa0\n-\n-\n-\n-\n-\n-\n-\n-\n1,473,434\n4,600,743\n\xa0(주)워랜텍\n-\n-\n-\n-\n-\n26,782\n-\n-\n518,225\n940,558\n\xa0(주)메디오젠\n-\n-\n-\n-\n-\n-\n-\n234,570\n5,021,194\n5,510,657\n\xa0(주)지아이이노베이션\n-\n-\n-\n-\n-\n-\n-\n-\n5,500,000\n5,500,000\n\xa0(주)네오딘바이오벳\n-\n-\n-\n-\n-\n-\n-\n-\n50,000\n50,000\n\xa0에스비바이오팜(주)\n-\n-\n-\n-\n-\n-\n-\n-\n2,169,128\n2,169,128\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0소 계\n-\n-\n650,828\n1,623,427\n900\n29,482\n-\n22,522,870\n45,443,081\n102,440,017\n(기타특수관계자)\n\xa0(주)리드팜\n646,357\n1,915,607\n-\n-\n-\n-\n-\n-\n1,910\n5,392\n\xa0(주)내츄럴엔도텍\n-\n-\n-\n-\n-\n-\n-\n2\n-\n31,863\n\xa0류신(칭다오)건강(유)\n-\n-\n-\n-\n-\n-\n-\n-\n1,568\n1,568\n\xa0(주)유앤생명과학\n-\n-\n-\n-\n-\n-\n-\n-\n76,595\n76,595\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0소 계\n646,357\n1,915,607\n-\n-\n-\n-\n-\n2\n80,073\n115,418\n합 계\xa0\n649,722\n1,922,226\n936,626\n2,573,785\n106,454\n181,644\n-\n22,522,872\n133,072,743\n276,253,560\n(3) 당분기말과 전기말 현재 특수관계자와의 채권ㆍ채무는 다음과 같습니다.\n\xa0(단위:천원)\n특수관계자 명칭\n매출채권\n매입채무\n미수금 등 기타자산\n예수보증금\n당분기말\n전기말\n당분기말\n전기말\n당분기말\n전기말\n당분기말\n전기말\n(종속기업)\n\xa0(주)유한화학\n-\n-\n9,992,984\n8,340,349\n-\n-\n-\n-\n\xa0(주)유한메디카\n-\n-\n-\n-\n-\n-\n400,000\n400,000\n\xa0(주)엠지\n-\n-\n2,855,820\n2,430,683\n2,200,000\n2,200,000\n520,000\n520,000\n\xa0(주)유한건강생활\n73,353\n92,148\n1,398,305\n901,609\n-\n-\n796,800\n796,800\n\xa0애드파마(주)\n-\n-\n-\n1,198,296\n4,510,574\n4,968,729\n-\n-\n\xa0암호명케이문화산업전문(유)\n-\n-\n-\n-\n40,000\n-\n소 계\n73,353\n92,148\n14,247,109\n12,870,937\n6,750,574\n7,168,729\n1,716,800\n1,716,800\n(관계기업 및 공동기업)\n\xa0(주)유칼릭스\n-\n-\n-\n132\n-\n-\n-\n-\n\xa0(주)유한크로락스\n441,364\n533,462\n14,640,792\n13,877,347\n-\n-\n-\n-\n\xa0유한킴벌리(주)\n-\n-\n59,400\n88,506\n-\n-\n-\n-\n\xa0(주)한국얀센\n33,359\n-\n6,973,556\n6,591,913\n-\n-\n-\n-\n\xa0(주)이뮨온시아\n343\n343\n-\n-\n-\n94,346\n-\n-\n\xa0(주)씨.앤.씨\n-\n-\n1,353,130\n1,326,742\n-\n-\n-\n-\n\xa0(주)워랜텍\n-\n-\n1,084,765\n777,538\n-\n-\n-\n-\n\xa0(주)메디오젠\n-\n-\n203,731\n5,309,619\n-\n-\n-\n-\n\xa0에스비바이오팜(주)\n-\n-\n983,453\n3,288,226\n11,600,729\n-\n-\n-\n\xa0메디라마(주)\n-\n-\n-\n-\n-\n-\n42,000\n-\n소 계\n475,066\n533,805\n25,298,827\n31,260,023\n11,600,729\n94,346\n42,000\n-\n(기타특수관계자)\n\xa0(주)리드팜\n383,094\n510,481\n-\n-\n-\n-\n-\n-\n\xa0류신(칭다오)건강(유)\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0(주)유앤생명과학\n-\n-\n-\n84,254\n-\n-\n-\n-\n소 계\n383,094\n510,481\n-\n84,254\n-\n-\n-\n-\n합 계\n931,513\n1,136,434\n39,545,936\n44,215,214\n18,351,303\n7,263,075\n1,758,800\n1,716,800\n(4) 당분기 및 전분기 중 특수관계자와의 자금거래 내역은 다음과 같습니다.\n(단위: 천원)\n특수관계 구분\n회사명\n당분기\n전분기\n대여\n회수\n출자\n대여\n회수\n출자\n종속기업\n(주)유한화학\n-\n-\n30,000,000\n-\n-\n-\nYUHAN UZBEKISTAN\n-\n-\n30,502\n-\n-\n226,360\n(주)유한건강생활\n-\n-\n6,900,608\n-\n-\n5,438,142\nYUHAN USA CORPORATION\n-\n-\n7,713,600\n-\n-\n6,367,400\n(주)엠지\n-\n-\n907,200\n-\n-\n21,314,140\n애드파마(주)\n-\n-\n7,000,000\n-\n-\n-\n암호명케이문화산업전문(유)\xa0\n-\n-\n2,400,000\n-\n-\n-\n(주)에이투젠\n-\n-\n10,532,691\n-\n-\n-\n관계기업 및 공동기업\n(주)지아이이노베이션\n-\n-\n-\n-\n-\n9,999,990\n(주)제이인츠바이오\n-\n-\n1,999,997\n-\n-\n-\n메디라마(주)\n-\n-\n1,499,971\n-\n-\n-\n(주)테라베스트\n-\n-\n2,999,984\n-\n-\n2,999,988\n(주)온코마스터\n-\n-\n1,999,850\n-\n-\n-\n(주)에이프릴바이오\n-\n-\n-\n-\n-\n10,000,066\n(주)아임뉴런바이오사이언스\n-\n-\n-\n-\n-\n2,000,004\n에스비바이오팜(주)\n-\n-\n-\n-\n-\n6,999,931\n(주)네오딘바이오벳\n-\n-\n-\n-\n-\n6,499,961\n주노랩(주)\n-\n-\n-\n-\n-\n300,000\n(5) 당분기말 현재 회사가 특수관계자에게 제공한 지급보증 및 담보 내역은 다음과 같습니다.\n(단위: 천원)\n특수관계자의 명칭\n보증 등의 내용\n금융기관\n보증 금액\n(종속기업)\n(주)유한건강생활\n일반대출\n신한은행\n3,600,000\n애드파마(주)\n운전자금대출\n하나은행\n6,000,000\n합 \xa0계\n9,600,000\n(6) 회사는 등기이사 및 회사 기업활동의 계획, 운영 및 통제에 대한 중요한 권한과 책임을 가진 등기 임원을 주요 경영진으로 판단하고 있으며, 당분기 및 전분기 중 주요 경영진에 대한 보상금액은 다음과 같습니다.\n(단위:천원)\n구 \xa0분\n당분기\n전분기\n3개월\n누적\n3개월\n누적\n단기종업원급여\n707,730\n1,847,227\n831,617\n2,943,570\n퇴직급여\n95,798\n287,393\n122,024\n366,072\n합 계\n803,528\n2,134,620\n953,641\n3,309,642\n']"
